F-Actin Fluorescence Lifetime Assay for High-Throughput Binding Screens
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for evaluating F-actin binding to actin-binding proteins (ABPs) are time-consuming and limited in throughput, making them inefficient for high-throughput screening of compounds that modulate actin-protein interactions, particularly in the context of heart diseases like cardiomyopathy.
Innovation Solution
A high-throughput assay using time-resolved fluorescence (TR-F) with fluorescence lifetime plate readers and fluorescent probes attached to F-actin at Cys374 to measure binding changes, allowing for rapid evaluation of actin-protein interactions and identification of modulating compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional cosedimentation assays are used to evaluate F-actin binding to actin-binding proteins, then measurement precision is maintained, but productivity is reduced due to time-consuming multiple steps and limited throughput
Solution Approach 1:
The patent replaces the mechanical cosedimentation system with a fluorescence-based optical detection system. Fluorescent probes attached to F-actin emit fluorescence upon binding to actin-binding proteins, allowing rapid detection without mechanical separation steps. This substitution enables high-throughput screening while maintaining measurement precision through fluorescence intensity quantification.
Solution Approach 2:
The patent changes the detection parameter from physical separation (cosedimentation) to optical signal (fluorescence emission). By attaching fluorescent probes to F-actin and measuring fluorescence intensity changes upon protein binding, the assay transforms a time-consuming mechanical process into a rapid optical measurement, significantly improving productivity and reducing assay time.
2Productivity
If fluorescent probes are attached to F-actin at Cys374 for time-resolved fluorescence detection, then productivity is improved through rapid evaluation, but device complexity increases due to requirement for fluorescence lifetime plate readers
Solution Approach 1:
The patent introduces fluorescent probes as intermediary molecules that bridge F-actin and the detection system. These probes emit fluorescence upon binding to actin-binding proteins, serving as a detectable signal that simplifies the overall system. The fluorescent probe acts as a mediator between the biological interaction and the measurement instrument, enabling rapid screening.
Solution Approach 2:
The patent creates a fluorescent copy or signal representation of the F-actin-protein interaction. Instead of directly measuring the physical binding event, the system uses fluorescent probes that produce an optical signal copy of the interaction, which can be rapidly detected and quantified by fluorescence lifetime plate readers, thereby improving screening speed.
3Productivity
If time-resolved fluorescence technique is used to detect actin-protein binding changes, then productivity is enhanced for high-throughput screening, but measurement precision requirements increase due to need for fluorescence lifetime analysis
Solution Approach 1:
The patent employs time-resolved fluorescence measurement, which involves periodic or sequential detection of fluorescence emission over time. By measuring the fluorescence lifetime (the time for excited states to decay), the system obtains precise kinetic information about protein binding events, enabling high-throughput screening with maintained measurement precision through automated lifetime analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates faster and more functional detection of actin-protein binding, enabling effective screening for therapeutic compounds targeting ABPs, particularly in heart diseases, with results comparable to traditional cosedimentation methods.
Implementation Method 1
fluorescent probes attached to F-actin at Cys374... time-resolved fluorescence (TR-F)... fluorescence lifetime plate reader
Data Source
AI summary
Protein biosensors for drug discovery, such as a high-throughput assay utilizing TR-F to detect the properties of binding proteins (e.g., actin-binding proteins, ABPs) using a fluorescence lifetime plate reader and fluorescent probes. In particular, the present invention is a new use of TR-F technique to rapidly evaluate binding of F-actin (− or +Tm) with cMyBP-C in solution. Changes in labeled actin fluorescence lifetime due to cMyBP-C phosphorylation and/or HCM mutations correlated with binding measured by traditional cosedimentation. The present invention features methods for HTS for identifying molecules that modulate cMyBP-C or cMyBP-C-actin complex.